MIAMI, FL. JUNE 12, 2018 — ArisGlobal, LLC, a leading provider of integrated cloud-based software solutions for life sciences, will present will present at the 2nd World Congress on Regulatory Affairs for Medical Devices to be held in London, UK, from July 2-3, 2018, on the topic “Can Medical Devices Learn from Pharma: Shared Challenges, Similar Opportunities!”
David Scanlon, Senior Director Regulatory Strategy at ArisGlobal, will present on July 2, 1:30 to 2:00 pm, as part of the conference’s session 2 track. Mr. Scanlon will draw upon the similarities and differences observed between the pharmaceutical and medical device industries, and will describe the potential opportunities to leverage learning from both industries as they move towards more global regulatory coherence.
“My session will focus on how data can be viewed as an asset, opening up opportunities for automation and productivity gains,” said David. “This will require more integrated end-to-end (E-2-E) solutions that have data governance and data exploitation enabled within their design.”
ArisGlobal is an exhibitor (Booth #2) and will be showcasing LifeSphere® Regulatory, its cognitive computing platform for regulatory affairs, and REGISTER for Medical Devices, the Regulatory Information Management System (RIMS) that enables real-time tracking throughout every step of the device registration process. Attendees are invited to meet with ArisGlobal staff to learn about its innovative and leading regulatory affairs platform.
ArisGlobal Launches LifeSphere NavaX™ 
